Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future

被引：10
作者：
Gao, Feng [1 ]
Chen, Gang [2 ,3 ,4 ]
Byrne, Christopher D. [5 ,6 ]
Targher, Giovanni [7 ,8 ]
Cheung, Tan To [9 ]
Zheng, Ming-Hua [10 ,11 ,12 ,13 ]
机构：
[1] Wenzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Wenzhou, Peoples R China
[3] Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Dis, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Hepatobiliary Pancreat Tumor Bioengn Cross Int Joi, Affiliated Hosp 1, Wenzhou, Peoples R China
[5] Univ Hosp Southampton, Southampton Natl Inst Hlth & Care Res, Biomed Res Ctr, Southampton, England
[6] Univ Southampton, Southampton Gen Hosp, Southampton, England
[7] Univ Verona, Dept Med, Verona, Italy
[8] IRCCS Sacro Cuore Don Calabria Hosp, I-37024 Negrar Di Valpolicella, Italy
[9] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Peoples R China
[10] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, NAFLD Res Ctr, Wenzhou, Peoples R China
[11] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[12] Key Lab Diag & Treatment Dev Chron Liver Dis Zheji, Wenzhou, Peoples R China
[13] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, 2 Fuxue Lane, Wenzhou 325000, Peoples R China
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2023年 / 12卷 / 06期
基金：
中国国家自然科学基金;
关键词：
Metabolic dysfunction-associated fatty liver disease (MAFLD); metabolic dysfunction-associated steatotic liver disease; nonalcoholic fatty liver disease; hepatocellular carcinoma (HCC); epidemiology;
D O I：
10.21037/hbsn-23-539
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：945 / 948
页数：4
相关论文
共 15 条
  • [1] From NASH to HCC: current concepts and future challenges
    Anstee, Quentin M.
    Reeves, Helen L.
    Kotsiliti, Elena
    Govaere, Olivier
    Heikenwalder, Mathias
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (07) : 411 - 428
  • [2] A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
    Eslam, Mohammed
    Newsome, Philip N.
    Sarin, Shiv K.
    Anstee, Quentin M.
    Targher, Giovanni
    Romero-Gomez, Manuel
    Zelber-Sagi, Shira
    Wong, Vincent Wai-Sun
    Dufour, Jean-Francois
    Schattenberg, Joern M.
    Kawaguchi, Takumi
    Arrese, Marco
    Valenti, Luca
    Shiha, Gamal
    Tiribelli, Claudio
    Yki-Jarvinen, Hannele
    Fan, Jian-Gao
    Gronbaek, Henning
    Yilmaz, Yusuf
    Cortez-Pinto, Helena
    Oliveira, Claudia P.
    Bedossa, Pierre
    Adams, Leon A.
    Zheng, Ming-Hua
    Fouad, Yasser
    Chan, Wah-Kheong
    Mendez-Sanchez, Nahum
    Ahn, Sang Hoon
    Castera, Laurent
    Bugianesi, Elisabetta
    Ratziu, Vlad
    George, Jacob
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 202 - 209
  • [3] Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
    Feng, Gong
    Valenti, Luca
    Wong, Vincent Wai-Sun
    Fouad, Yasser Mahrous
    Yilmaz, Yusuf
    Kim, Won
    Sebastiani, Giada
    Younossi, Zobair M.
    Hernandez-Gea, Virginia
    Zheng, Ming-Hua
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (01) : 46 - 56
  • [4] Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
    Huang, Daniel Q.
    El-Serag, Hashem B.
    Loomba, Rohit
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2021, 18 (04) : 223 - 238
  • [5] Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
    Llovet, Josep M.
    Willoughby, Catherine E.
    Singal, Amit G.
    Greten, Tim F.
    Heikenwaelder, Mathias
    El-Serag, Hashem B.
    Finn, Richard S.
    Friedman, Scott L.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (08) : 487 - 503
  • [6] Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
    Lonardo, Amedeo
    Mantovani, Alessandro
    Petta, Salvatore
    Carraro, Amedeo
    Byrne, Christopher D.
    Targher, Giovanni
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2022, 18 (10) : 638 - 650
  • [7] AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review
    Loomba, Rohit
    Lim, Joseph K.
    Patton, Heather
    El-Serag, Hashem B.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : 1822 - 1830
  • [8] An elevated FIB-4 score predicts liver cancer development: A longitudinal analysis from 29,999 patients with NAFLD
    Loosen, Sven H.
    Kostev, Karel
    Keitel, Verena
    Tacke, Frank
    Roderburg, Christoph
    Luedde, Tom
    [J]. JOURNAL OF HEPATOLOGY, 2022, 76 (01) : 247 - +
  • [9] Clinical Patterns of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Multicenter Prospective Study
    Piscaglia, Fabio
    Svegliati-Baroni, Gianluca
    Barchetti, Andrea
    Pecorelli, Anna
    Marinelli, Sara
    Tiribelli, Claudio
    Bellentani, Stefano
    [J]. HEPATOLOGY, 2016, 63 (03) : 827 - 838
  • [10] Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
    Rios, Rafael S.
    Zheng, Kenneth, I
    Zheng, Ming-Hua
    [J]. CHINESE MEDICAL JOURNAL, 2021, 134 (24) : 2911 - 2921
12